Lan Huang
Chief Executive Officer presso BEYONDSPRING INC.
Patrimonio netto: 36 M $ in data 31/03/2024
Profilo
Lan Huang is the founder of Dalian Wanchun Biotechnology Co. Ltd.
(2010), Paramax International, Inc. (2008), BeyondSpring, Inc. (2013), and Wuxi Mtlh Biotechnology Co. Ltd.
(2007).
She is also the founder of Seed Therapeutics, Inc., Seed Therapeutics, Inc. (Pennsylvania).
Currently, Dr. Huang is the Chairman & Chief Executive Officer at BeyondSpring Pharmaceuticals, Inc. She previously held the position of Trustee at Lawrence University (2012-2015).
Dr. Huang received her undergraduate degree from Lawrence University and her doctorate from the University of California, Berkeley.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BEYONDSPRING INC.
26.17% | 31/12/2023 | 10 210 523 ( 26.17% ) | 36 M $ | 31/03/2024 |
Posizioni attive di Lan Huang
| Società | Posizione | Inizio |
|---|---|---|
| BEYONDSPRING INC. | Chief Executive Officer | 01/11/2014 |
Wuxi Mtlh Biotechnology Co. Ltd.
 Wuxi Mtlh Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Wuxi Mtlh Biotechnology Co. Ltd. is a private company based in Wuxi, China that develops anti-cancer drugs. The Chinese company was founded by Lan Huang and Lan Huang has been the CEO since incorporation. | Chief Executive Officer | 01/01/2010 |
BeyondSpring Pharmaceuticals, Inc.
 BeyondSpring Pharmaceuticals, Inc. BiotechnologyHealth Technology Part of BeyondSpring, Inc., BeyondSpring Pharmaceuticals, Inc. is a clinical-stage bio-pharmaceutical company that develops innovative immuno-oncology cancer therapies. The private company is based in New York, NY. The company has a robust pipeline from internal development and collaboration with the University of Washington in de novo drug discovery using a ubiquitination platform. The CEO of the company is Lan Huang. | Chief Executive Officer | - |
| Seed Therapeutics, Inc.(Pennsylvania) | Chief Executive Officer | - |
| Seed Therapeutics, Inc. | Chief Executive Officer | - |
Precedenti posizioni note di Lan Huang
| Società | Posizione | Fine |
|---|---|---|
| Lawrence University | Director/Board Member | 01/01/2015 |
| Dalian Wanchun Biotechnology Co. Ltd. | Founder | - |
Paramax International, Inc.
 Paramax International, Inc. Medical/Nursing ServicesHealth Services Part of ICON plc, Paramax International, Inc. is a Chinese company that provides clinical research services. The private company is based in Beijing, China. The company was founded by Lan Huang. Paramax International was acquired by ReSearch Pharmaceutical Services LLC, part of ICON plc from August 21, 2013 on July 07, 2009 for $1.53 million. | Founder | - |
Formazione di Lan Huang
| Lawrence University | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BEYONDSPRING INC. | Health Technology |
| Aziende private | 6 |
|---|---|
BeyondSpring Pharmaceuticals, Inc.
BeyondSpring Pharmaceuticals, Inc. BiotechnologyHealth Technology Part of BeyondSpring, Inc., BeyondSpring Pharmaceuticals, Inc. is a clinical-stage bio-pharmaceutical company that develops innovative immuno-oncology cancer therapies. The private company is based in New York, NY. The company has a robust pipeline from internal development and collaboration with the University of Washington in de novo drug discovery using a ubiquitination platform. The CEO of the company is Lan Huang. | Health Technology |
Wuxi Mtlh Biotechnology Co. Ltd.
Wuxi Mtlh Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Wuxi Mtlh Biotechnology Co. Ltd. is a private company based in Wuxi, China that develops anti-cancer drugs. The Chinese company was founded by Lan Huang and Lan Huang has been the CEO since incorporation. | Health Technology |
| Dalian Wanchun Biotechnology Co. Ltd. | |
| Seed Therapeutics, Inc. | |
| Seed Therapeutics, Inc.(Pennsylvania) | |
Paramax International, Inc.
Paramax International, Inc. Medical/Nursing ServicesHealth Services Part of ICON plc, Paramax International, Inc. is a Chinese company that provides clinical research services. The private company is based in Beijing, China. The company was founded by Lan Huang. Paramax International was acquired by ReSearch Pharmaceutical Services LLC, part of ICON plc from August 21, 2013 on July 07, 2009 for $1.53 million. | Health Services |
- Borsa valori
- Insiders
- Lan Huang
